Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease

Affiliations

Comment

Say-Yee Loo et al. Hepatobiliary Surg Nutr. 2017 Apr.

. 2017 Apr;6(2):135-137.

doi: 10.21037/hbsn.2017.03.06.

¹ Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
Unalp-Arida A, Ruhl CE. Unalp-Arida A, et al. Hepatology. 2016 Apr;63(4):1170-83. doi: 10.1002/hep.28390. Epub 2016 Jan 22. Hepatology. 2016. PMID: 26663021 Free PMC article.

1. Unalp-Arida A, Ruhl CE. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. Hepatology 2016;63:1170-83. 10.1002/hep.28390 - DOI - PMC - PubMed
1. Kim D, Kim WR, Kim HJ, et al. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013;57:1357-65. 10.1002/hep.26156 - DOI - PMC - PubMed
1. Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-49. 10.3109/07853890.2010.518623 - DOI - PubMed
1. Ekstedt M, Hagström H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015;61:1547-54. 10.1002/hep.27368 - DOI - PubMed
1. Singh S, Fujii LL, Murad MH, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1573-84.e1-2; quiz e88-9. - PMC - PubMed